September 26, 2017

Orffa presents benchmark study at inaugural Mycokey congress

 

At the inaugural Mycokey congress held in Ghent, Belgium from September 11-14, Orffa presented a benchmark study on mycotoxin binders.

The 1st Mycokey congress, organised by the research platform MYTOX, was attended by representatives from universities and the industry. Several African and Asian partners of the MYTOX platform were also present. The congress focused on the reduction of the global mycotoxin presence in the feed and food chain.

For more than five years, Orffa has been working on a complete mycotoxin binder composition, tailored to the co-occurrence of multiple mycotoxins in feed and reducing the negative impact on the health status of production animals. Multiple in vitro trials were performed to assess the binding capacity of single ingredients and formed the basis for the development of a commercial preparation, Excential Toxin Plus, consisting of five ingredients. This composition was benchmarked against 19 commercial available preparations (including six premium quality products). The in vitro experiments were designed in close collaboration with MYTOX and executed by the Laboratory of Food Analysis at Ghent University.

The benchmark study showed that all commercial products tested show a very high binding towards aflatoxins and enniatin B. In comparison, trichothecenes are difficult to bind at any pH. A very high recovery in the supernatants can be distinguished for DON, suggesting biotransformation by any binder into less toxic metabolites is minimal. Fumonisins and ochratoxins are also difficult to bind, especially at pH 7. The tested products show a large variation in the binding of zearalenone. In conclusion, there are differences between commercial mycotoxin binders for feed applications, with some binders have a higher binding efficiency towards specific mycotoxins.

Excential Toxin Plus, manufactured by Orffa, is being sold and marketed on a global level.

More information on the benchmark study can be found at https://www.orffa.com/benchmark-study-commercial-mycotoxin-binders-presented-1st-mycokey-congress/